According to a new study from Pfizer and BioNTech, a third dose of the vaccine significantly raises Omicron-fighting antibodies.
vaccine for children ages 5 through 11, citing promising data collected from children who received a third dose at least six months after their second dose.COVID-19 infectionResearchers looked at a subset of 30 children in this group a month after their third dose and found that antibodies protecting against the Omicron variant were 36 times higher than they were before receiving the third dose.
The study did not report any new safety issues among the children in the booster trial. The results, according to a, "reinforce the potential function of a third dose of the vaccine in maintaining high levels of protection against the virus in this age group.” During the midst of the Omicron surge, researchers from the New York State Department of Health reported that the standard two doses of the Pfizer vaccine wasn’t effective at protecting against the highly transmissible variant.from Centers for Disease Control found that while vaccine effectiveness had dropped during Omicron’s surge and decreased with time post-vaccination, the vaccine dramatically lowered the risk of hospitalization or death.
Vaccines for children ages 5 through 11 were first authorized by the CDC in early November 2021. According to the CDC, there are 28 million American kids in that
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid booster shot bolsters protection in 5-to-11-year-olds, Pfizer and BioNTech sayThe third shot appears to broaden the ability of the immune system to recognize variants such as omicron.
Read more »
Pfizer Says Covid-19 Booster in Children Ages 5 to 11 Sparked Immune Response Against OmicronA booster shot of the Pfizer-BioNTech Covid vaccine in children ages 5 to 11 significantly increased antibody levels against the Omicron variant as well as against the initial strain it was designed to fight, a late-stage study found.
Read more »
Pfizer says booster in children 5-11 raises antibodies against omicronThe company says it plans to submit its data to the FDA for authorization.
Read more »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsPfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized shot.
Read more »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsPfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized shot.
Read more »
COVID-19 booster: Pfizer to seek extra shot for healthy kids 5 to 11Pfizer said new data shows its kid-sized COVID-19 booster could help healthy elementary-aged children rev up virus-fighting antibodies and plans to seek authorization soon.
Read more »